Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study

BACKGROUND: Current evidence suggests that intravenous magnesium sulfate might be effective for reducing migraine pain. In a recent pilot study, we showed that intravenous caffeine citrate could reduce the severity of migraine headache. The objective of this study is to investigate the efficacy of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Baratloo, Alireza, Mirbaha, Sahar, Delavar Kasmaei, Hossein, Payandemehr, Pooya, Elmaraezy, Ahmed, Negida, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pain Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532524/
https://www.ncbi.nlm.nih.gov/pubmed/28757917
http://dx.doi.org/10.3344/kjp.2017.30.3.176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532524/
https://www.ncbi.nlm.nih.gov/pubmed/28757917
http://dx.doi.org/10.3344/kjp.2017.30.3.176

Ejemplares similares